Joan W. Miller

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

Localization of rose bengal, aluminum phthalocyanine tetrasulfonate, and chlorin e6 in the rabbit eye.

Expression of pigment epithelium-derived factor in experimental choroidal neovascularization.

Mechanisms of age-related macular degeneration.

Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.

Caspase activation in an experimental model of retinal detachment.

Improvement after verteporfin therapy.

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

Photodynamic therapy for choroidal neovascularization. The Jules Gonin Lecture, Montreux, Switzerland, 1 September 2002.

Management of dislocated lens material.

Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization.

VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.

Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3.

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.

Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration.

Aptamers, intramers, and vascular endothelial growth factor.

Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration.

Ocular tissue permeabilities.

Photosensitizers in photodynamic therapy of choroidal neovascularization.

Treatment of chlamydial eye infections.

Expression of leukocyte adhesion molecules in human subfoveal choroidal neovascular membranes treated with and without photodynamic therapy.

Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.

Verteporfin in Photodynamic Therapy: report no. 5.

FAS-mediated apoptosis and its relation to intrinsic pathway activation in an experimental model of retinal detachment.

Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.

An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris neovascularization.

Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.

Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.

Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration.

Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.

Medical treatment of choroidal neovascularization secondary to age-related macular degeneration.

Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid.

Predictability and limitations of non-invasive murine tonometry: comparison of two devices.

Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.

Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.

Histologic correlation of in vivo optical coherence tomography images of the human retina.

Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture.

Using a drug before the risks and benefits are known from a phase 3 clinical trial: thoughts on compassion.

Characterization of cytokine responses to retinal detachment in rats.

Potential future targets for treating ocular neovascularization.

Proton beam irradiation for neovascular age-related macular degeneration.

Identification of resident and inflammatory bone marrow derived cells in the sclera by bone marrow and haematopoietic stem cell transplantation.

Introducing Evangelos S. Gragoudas, the 2006 recipient of the Weisenfeld Award.

Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma.

Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration.

Photodynamic therapy and combination treatments.

Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis.

Infection, inflammation and age-related macular degeneration.

Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis.

The role of inflammation and infection in age-related macular degeneration.

Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.

Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin.

Endogenous endostatin inhibits choroidal neovascularization.

The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.

Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model.

Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis.

Anti-vascular endothelial growth factor therapy for ocular neovascular disease.

Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration.

In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis.

Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.

DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity.

Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1.

Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization.

Pediatric ophthalmology. Preface.

Vascular adhesion protein-1 blockade suppresses choroidal neovascularization.

Preliminary results of gene therapy for retinal degeneration.

HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice.

The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration.

Age-related macular degeneration.

Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration.

Ocular pathology. Preface.

Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).

Pharmacological inhibition of mitochondrial membrane permeabilization for neuroprotection.

Seminars in Ophthalmology. Introduction.

Review of the ocular angiogenesis animal models.

Proliferative vitreoretinopathy: pathobiology and therapeutic targets.

Review of anti-VEGF therapy in proliferative diabetic retinopathy.

Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.

Introduction.

Judah Folkman.

Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.

Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach.

Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration.

A novel nonradioactive method to evaluate vascular barrier breakdown and leakage.

Legacy of the age-related eye disease [corrected] study.

Significant advances in cataract and refractive surgery over the last decade. Preface.

Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.

Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.

Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments.

Fundus autofluorescence in geographic atrophy: a review.

Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis.

Treatment of age-related macular degeneration: beyond VEGF.

In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography.

Edaravone, an ROS scavenger, ameliorates photoreceptor cell death after experimental retinal detachment.

Heat shock protein 70 (HSP70) is critical for the photoreceptor stress response after retinal detachment via modulating anti-apoptotic Akt kinase.

Displayed reflectivity of choroidal neovascular membranes by optical coherence tomography correlates with presence of leakage by fluorescein angiography.

Tumor necrosis factor-alpha mediates photoreceptor death in a rodent model of retinal detachment.

Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization.

RIP kinase-mediated necrosis as an alternative mechanisms of photoreceptor death.

Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics.

Anti-vascular endothelial growth factor monotherapy versus combination treatment with photodynamic therapy for subfoveal choroidal neovascularization secondary to causes other than age-related macular degeneration.

Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization.

Inhibitory effect of aminoimidazole carboxamide ribonucleotide (AICAR) on endotoxin-induced uveitis in rats.

An epigenetic approach toward understanding ocular α-herpesvirus pathogenesis and treatment.

Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment.

Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology.

Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity.

Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration.

Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse.

Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis.

The regulatory roles of apoptosis-inducing factor in the formation and regression processes of ocular neovascularization.

Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.

Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration.

Vascular endothelial growth factor a in intraocular vascular disease.

Age-related macular degeneration revisited--piecing the puzzle: the LXIX Edward Jackson memorial lecture.

Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis.

Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.

Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration.

AMP-dependent kinase inhibits oxidative stress-induced caveolin-1 phosphorylation and endocytosis by suppressing the dissociation between c-Abl and Prdx1 proteins in endothelial cells.

Photoreceptor cell death and rescue in retinal detachment and degenerations.